wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52816089-A828BDCB-D79E-44A9-8240-2979060E0A6A
Q52816089-A828BDCB-D79E-44A9-8240-2979060E0A6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52816089-A828BDCB-D79E-44A9-8240-2979060E0A6A
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
P2860
Q52816089-A828BDCB-D79E-44A9-8240-2979060E0A6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52816089-A828BDCB-D79E-44A9-8240-2979060E0A6A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d19ae5b382c9a6162088cd0d09ee23485b6bda52
P2860
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.